Literature DB >> 15617742

The frequency of cytochrome P450 2C9 genetic variants in the Russian population and their associations with individual sensitivity to warfarin therapy.

Sofya N Pchelina1, Olga V Sirotkina, Anastasiya E Taraskina, Tatyana V Vavilova, Alexander L Shwarzman, Eugene I Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15617742     DOI： 10.1016/j.thromres.2004.08.020

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  3 in total

1.  Clinical pharmacology in Russia-historical development and current state.

Authors:  Ksenia Zagorodnikova Goryachkina; Aleksandra Burbello; Dmitry Sychev; Maxim Frolov; Vladimir Kukes; Vladimir Petrov
Journal:  Eur J Clin Pharmacol       Date:  2014-12-04       Impact factor: 2.953

Review 2.  Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysis.

Authors:  Jonatan D Lindh; Lennart Holm; Marine L Andersson; Anders Rane
Journal:  Eur J Clin Pharmacol       Date:  2008-11-25       Impact factor: 2.953

Review 3.  Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.

Authors:  Andrea L Jorgensen; Richard J FitzGerald; James Oyee; Munir Pirmohamed; Paula R Williamson
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.